Stock Chart
HROW
Type: SELL growth_1yr
Strike: $33
Premium: $8.50
Expiry: Sep 17, 2027
Target: $27
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About HROW - Harrow, Inc. Common Stock
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx …
Key Statistics
More HROW Analysis
This HROW stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track HROW's price movements with trendlines, gamma walls, and key support/resistance levels.